What is Eton Pharmaceuticals, Inc.'s intangible purchases?

Eton Pharmaceuticals, Inc. (ETON) reported intangible purchases of $15M in Q1 2026.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s intangible purchases?

Over 2 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s intangible purchases has grown at a -100.0% compound annual growth rate (CAGR), from $3.25M to $0.

What does intangible purchases mean?

Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.

Eton Pharmaceuticals, Inc. ETON Intangible Purchases

Intangible Purchases at other companies

HRO

HarrowHROW

$9K-78.6%

Zevra Therapeutics, Inc.ZVRA

$0-100%

Ultragenyx PharmaceuticalRARE

$5M-66.7%

ANI PharmaceuticalsANIP

$5.25M-69.8%

Catalyst PharmaceuticalCPRX

$0—

Travere Therapeutics, Inc.TVTX

$22.18M+88.2%

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+162%

Enterprise value$942.39M+156%

P/S10.7×+3.4×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s intangible purchases?: Eton Pharmaceuticals, Inc. (ETON) reported intangible purchases of $15M in Q1 2026.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s intangible purchases?: Over 2 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s intangible purchases has grown at a -100.0% compound annual growth rate (CAGR), from $3.25M to $0.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.